查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2024198

家庭診斷市場：策略與趨勢—按應用、通路、技術和國家預測—市場分析與管理指南及人工智慧 (AI) 影響（2026-2030 年）

Home Diagnostics Markets Strategies and Trends. Forecasts by Application by Channel by Technology and by Country. With Market Analysis and Executive Guides. Including Impact of Artificial Intelligence. 2026 to 2030
出版日期: | 出版商: Howe Sound Research | 英文 405 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

報告摘要：

即時檢測（POC​​）居家診斷是體外診斷（IVD）產業成長最快的領域之一，反映了醫療服務分散化和病患更參與健康管理等更廣泛的趨勢。居家診斷檢測使個人能夠在傳統臨床環境之外進行醫學檢測，快速獲得結果，從而支持疾病的發現、監測和預防性健康管理。這些檢測為患者提供了獲取健康資訊的更大便利，同時減少了他們對某些類型檢測的檢查室就診和醫生諮詢的依賴。

全球即時檢測（POC​​）家用診斷市場預計到2025年將達到44.9億美元，年複合成長率為9.9%，預計到2030年將達到72億美元。這一成長是由對便捷醫療保健解決方案的需求不斷成長、遠距遠端醫療服務的擴展、生物感測器設計方面的技術進步以及消費者對預防性健康監測日益成長的興趣所推動的。

居家診斷技術在改善醫療保健服務可近性方面發揮著至關重要的作用，尤其對於需要頻繁監測慢性病患者和尋求快速篩檢感染疾病的人更是如此。消費者對居家檢測技術的了解不斷加深，尤其是在新冠病毒自測廣泛普及之後，促進了分散式診斷解決方案的更廣泛接受。

居家診斷測試的範圍

即時檢測 (POC) 家庭診斷市場涵蓋了廣泛的檢測類別，可同時滿足醫療和健康領域的需求。

傳染病檢查是至關重要的環節，包括呼吸道感染疾病、流感、新冠病毒和其他傳染病的快速檢測。居家檢測有助於早期發現感染疾病，並支持公共衛生措施以防止疾病傳播。

慢性病監測也是重要的一環。血糖值監測系統被糖尿病患者廣泛用於控制血糖值。其他慢性病監測應用包括膽固醇檢測、腎功能監測和凝血功能監測。

生殖健康檢測是家庭診斷市場中一個成熟的領域。驗孕棒和排卵預測試劑盒是廣泛使用的消費級診斷產品。不孕症監測系統也擴大融入了數位追蹤功能。

心臟代謝檢測的應用包括監測血脂譜和糖化血紅蛋白（HbA1c）檢測，用於糖尿病管理。

隨著消費者尋求有關營養、健身、老齡化和遺傳健康風險的個人化健康信息，基因檢測和健康檢測服務正在不斷擴展。

在某些市場，藥物檢測和毒理學篩檢應用程式也可供家庭使用。

生物感測器技術的進步使得開發能夠高靈敏度分析少量檢體的緊湊型診斷設備成為可能。

技術平台

家用診斷通常採用簡化版的臨床檢查室技術。橫向流動化驗因其操作簡便、結果快速，廣泛用於感染疾病快速檢測。

電化學生物感測器常用於血糖值監測系統和其他代謝檢測。

微流體技術使得檢查室流程小型化並將其整合到攜帶式診斷設備中成為可能。

數位連接使家庭診斷能夠將結果傳輸到智慧型手機應用程式和雲端健康平台。

與行動應用程式整合後，用戶可以追蹤他們的長期健康狀況趨勢。

感測器技術的進步提高了家庭診斷的靈敏度和可靠性。

自動化檢測程序可以減少使用者對技術技能的依賴。

此連接功能允許將家庭檢測數據與遠端醫療平台整合。

市場促進因素

多種因素正在推動家庭照護現場診斷市場的成長。

糖尿病和心血管疾病等慢性病的日益普遍，使得人們對更頻繁的健康監測產生了需求。

隨著遠端醫療服務的擴展，居家診斷正擴大被納入遠距患者照護流程。

消費者對個人化健康資訊的興趣日益濃厚，推動了對健康檢測服務的需求成長。

醫療系統正在尋求經濟有效的方法來減輕臨床機構的負擔。

生物感測器小型化技術的進步使得開發方便用戶使用的檢測設備成為可能。

人們對感染疾病傳播途徑的認知不斷提高，推動了對快速居家檢測解決方案的需求。

在高齡化社會中，便捷的居家診斷檢測可能具有重要意義。

數位健康平台正在改善人們獲取健康數據的途徑。

遠端患者監護計畫正在推動家用檢測設備的普及。

市場區隔

由於北美地區消費者對數位醫療技術的接受度很高，因此該地區是一個重要的區域市場。

歐洲已成為一個重要的市場，這得益於其對醫療創新的投入。

由於醫療保健服務的普及和智慧型手機的廣泛應用，亞太市場正在不斷擴大。

新興市場由於醫療基礎設施有限，可能會受益於分散式診斷解決方案。

競爭格局

照護現場診斷市場包括診斷設備製造商、消費者健康公司、數位健康平台開發商和生物技術公司。

競爭的促進因素包括產品的精準性、易用性、品牌知名度和數位連結功能。

消費者信任是影響產品廣泛普及的關鍵因素。

各公司正日益開發將診斷測試和行動應用程式結合的整合式數位健康生態系統。

診斷設備製造商與遠端醫療服務提供者之間的策略合作夥伴關係正變得越來越普遍。

透過使用者友善的設計和數位化整合功能可以實現產品差異化。

直接面對消費者的行銷策略在產品推廣中扮演著至關重要的角色。

例如，經常性收入模式可以包括檢測用品的訂閱服務。

未來展望

隨著醫療保健系統越來越重視便利性、可近性和患者參與度，預計即時檢測 (POC) 家庭診斷市場將繼續擴張。

生物感測器技術的進步可能會推動更先進的家用檢測解決方案的開發。

將居家遠端醫療平台結合，有可能改善醫療服務的協調性。

使用人工智慧 (AI) 工具可以提高對居家檢測結果的解讀準確性。

遠端患者監護計畫的擴展可能會促使家用診斷設備的普及。

消費者對預防性健康管理的興趣預計將支撐市場的長期成長。

整體而言，居家照護現場診斷已成為分散式醫療服務的重要組成部分。數位健康技術、生物感測器和連接平台的持續進步有望支撐市場的持續成長。

目錄

第1章 市集指南

  • 情境分析
  • 高階主管和行銷負責人的指南
  • 投資分析師和管理顧問指南
  • 人工智慧的影響

第2章：引言與市場定義

第3章 行業概覽

  • 參與企業充滿活力的市場
    • 學術研究辦公室
    • 診斷測試開發人員
    • 測量儀器供應商
    • 化學品/試劑供應商
    • 病理檢測用品供應商
    • 獨立臨床實驗室
    • 國家/地區公共研究機構
    • 醫院檢查室
    • 醫師診所檢查室(POLS)
    • 審計機構
    • 認證機構
  • 診斷市場區隔
  • 產業結構

第4章 市場趨勢

  • 成長促進因素
  • 成長阻礙因素
  • 診斷技術發展

第5章：居家診斷的最新趨勢

第6章：主要家用診斷設備製造商概覽

  • 1DropDiagnostics
  • 23andME Inc.
  • Abbott Laboratories
  • Accel Diagnostics
  • ADT Biotech
  • Akonni Biosystems
  • AlphaBiolabs
  • Alveo Technologies
  • Anitoa
  • Applied BioCode
  • Atomo Diagnostics
  • Aureum Diagnostics
  • Aus Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • BioFire Diagnostics（bioMerieux）
  • bioMerieux Diagnostics
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Cepheid（Danaher）
  • Cue Health
  • Curetis（OpGen）
  • DBS Systems
  • Detect
  • Diagenode Diagnostics（Hologic）
  • Diasorin SpA
  • Domus Diagnostics
  • Ellume
  • Everywell
  • Genomadix
  • Getlabs
  • Grip Molecular Technologies
  • Healthy.io
  • Hologic
  • Inflammatix
  • Invetech
  • Iollo
  • J&J Innovative Medicine
  • Karius
  • Laboratory Corporation of America
  • Letsgetchecked
  • LightDeck Diagnostics
  • Lucira Health（Pfizer）
  • LumiraDx
  • Meep
  • MFB Fertility
  • myLabBox
  • NanoDx
  • Nanomix
  • OraSure Technologies
  • Oxford Nanopore Technologies
  • Panagene
  • Prenetics
  • Primerdesign（Novacyt）
  • Prominex
  • Proof Diagnostics
  • Qiagen
  • QuantuMDx
  • Quest Diagnostics
  • QuidelOrtho
  • Randox Toxicology
  • Roche Diagnostics
  • Salignostics
  • SD Biosensor
  • Seegene
  • Siemens Healthineers
  • T2 Biosystems
  • TestCard
  • Thermo Fisher Scientific
  • Thriva
  • Visby Medical
  • XCR Diagnostics
  • YourBio Health

第7章 世界市場規模

  • 全球家庭診斷市場規模（按國家/地區分類）
  • 全球家用診斷市場規模（按應用領域分類）
  • 全球家庭診斷市場規模（按通路分類）
  • 全球家用診斷市場規模（依技術分類）

第8章 按應用程式分類的世界市場

  • 呼吸系統
  • STD
  • UTI
  • 懷孕
  • 排卵
  • DNA
  • 其他

第9章 全球市場通路

  • 店鋪
  • 線上
  • 其他

第10章 世界技術市場

  • 免疫檢測
  • 化學
  • 核酸
  • 其他

第11章附錄

表格一覽

圖表清單

簡介目錄
Product Code: POCHOME 426

Report Overview:

Point-of-Care (POC) Home Diagnostics represent one of the fastest growing segments of the in vitro diagnostics (IVD) industry, reflecting a broader shift toward decentralized healthcare delivery and increased patient engagement in health management. Home diagnostic tests allow individuals to perform medical testing outside traditional clinical settings, providing rapid results that support disease detection, monitoring, and preventive health management. These tests enable patients to access health information more conveniently while reducing dependence on laboratory visits or physician appointments for certain types of testing.

The global POC home diagnostics market is estimated to be USD 4.49 billion in 2025 and is expected to grow at compound annual growth rates of 9.9% to reach USD 7.2 Billion in 2030. Growth is supported by increasing demand for convenient healthcare solutions, expansion of telehealth services, technological advances in biosensor design, and increasing consumer interest in proactive health monitoring.

Home diagnostic technologies play an important role in improving healthcare accessibility, particularly for patients requiring frequent monitoring of chronic conditions or individuals seeking rapid screening for infectious diseases. Increased consumer familiarity with home testing technologies, particularly following widespread use of COVID-19 self-tests, has contributed to growing acceptance of decentralized diagnostic solutions.

Scope of Home Diagnostic Testing

The POC home diagnostics market includes a wide range of test categories addressing both medical and wellness applications.

Infectious disease testing represents a significant segment, including rapid tests for respiratory infections, influenza, COVID-19, and other communicable diseases. Home testing enables early identification of infectious conditions and supports public health efforts to reduce disease transmission.

Chronic disease monitoring tests represent another important segment. Blood glucose monitoring systems are widely used by patients with diabetes to manage blood sugar levels. Additional chronic disease monitoring applications include cholesterol testing, kidney function monitoring, and coagulation monitoring.

Reproductive health testing represents a well-established segment of the home diagnostics market. Pregnancy tests and ovulation prediction kits are widely used consumer diagnostic products. Fertility monitoring systems increasingly incorporate digital tracking capabilities.

Cardiometabolic testing applications include lipid profile monitoring and HbA1c testing for diabetes management.

Genetic and wellness testing services are expanding as consumers seek personalized health insights related to nutrition, fitness, aging, and inherited health risks.

Drug testing and toxicology screening applications are also available for home use in certain markets.

Advances in biosensor technologies are enabling development of compact diagnostic devices capable of analyzing small sample volumes with high sensitivity.

Technology Platforms

Home diagnostic devices typically use simplified versions of technologies originally developed for clinical laboratories. Lateral flow assays are widely used for rapid infectious disease testing due to their ease of use and rapid result generation.

Electrochemical biosensors are commonly used in glucose monitoring systems and other metabolic tests.

Microfluidics technologies enable miniaturization of laboratory processes into portable diagnostic devices.

Digital connectivity features allow home diagnostic devices to transmit results to smartphone applications or cloud-based health platforms.

Integration with mobile applications enables users to track health trends over time.

Advances in sensor technology are improving sensitivity and reliability of home diagnostic devices.

Automation of test procedures reduces reliance on user technique.

Connectivity features enable integration of home testing data with telehealth platforms.

Market Drivers

Several factors are driving growth in the point-of-care home diagnostics market.

Increasing prevalence of chronic diseases such as diabetes and cardiovascular disease is creating demand for frequent health monitoring.

Expansion of telehealth services is increasing integration of home diagnostics into remote patient care pathways.

Consumer interest in personalized health insights is increasing demand for wellness testing services.

Healthcare systems are seeking cost-effective approaches to reduce burden on clinical facilities.

Technological advances in biosensor miniaturization are enabling development of user-friendly testing devices.

Increased awareness of infectious disease transmission is supporting demand for rapid home testing solutions.

Aging populations may benefit from convenient home-based diagnostic testing.

Digital health platforms are improving accessibility of health data.

Remote patient monitoring programs are increasing adoption of home testing devices.

Market Segmentation

North America represents a major regional market due to high consumer adoption of digital health technologies.

Europe represents a significant market supported by healthcare innovation initiatives.

Asia-Pacific markets are expanding due to increasing healthcare access and smartphone adoption.

Emerging markets may benefit from decentralized diagnostic solutions due to limited access to healthcare infrastructure.

Competitive Landscape

The point-of-care home diagnostics market includes diagnostic device manufacturers, consumer health companies, digital health platform developers, and biotechnology companies.

Competition is influenced by product accuracy, ease of use, brand recognition, and digital connectivity capabilities.

Consumer trust represents an important factor influencing product adoption.

Companies are increasingly developing integrated digital health ecosystems combining diagnostic testing with mobile applications.

Strategic partnerships between diagnostic companies and telehealth providers are becoming more common.

Product differentiation may be achieved through user-friendly design and digital integration features.

Direct-to-consumer marketing strategies play an important role in product adoption.

Recurring revenue models may include subscription services for test supplies.

Future Outlook

The POC home diagnostics market is expected to continue expanding as healthcare systems emphasize convenience, accessibility, and patient engagement.

Advances in biosensor technologies may enable development of more sophisticated home testing solutions.

Integration of home diagnostic data with telehealth platforms may improve care coordination.

Artificial intelligence tools may improve interpretation of home test results.

Expansion of remote patient monitoring programs may increase adoption of home diagnostic devices.

Consumer interest in preventive health management is expected to support long-term market growth.

Overall, point-of-care home diagnostics represent an important component of decentralized healthcare delivery. Continued advances in digital health technologies, biosensors, and connectivity platforms are expected to support sustained market expansion.

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
    • 1.1.1 Shift Toward Decentralized Healthcare Delivery
    • 1.1.2 Product Scope and Technology Platforms
    • 1.1.3 Accuracy, Reliability, and Clinical Validation
    • 1.1.4 Regulatory and Compliance Considerations
    • 1.1.5 Consumer Engagement and Usability Challenges
    • 1.1.6 Reimbursement and Economic Considerations
    • 1.1.7 Competitive Landscape and Market Structure
    • 1.1.8 Data Integration and Healthcare Connectivity
    • 1.1.9 Geographic Market Dynamics
    • 1.1.10 Outlook and Strategic Implications
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants
  • 1.4 Impact of Aritificial Intelligence

2 Introduction and Market Definition

  • 2.1 What are Home Diagnostics?
  • 2.2 Home Testing - the quiet revolution in diagnostics
  • 2.3 Self vs. Send vs. In House - Who knew?
    • 2.3.1 Self
    • 2.3.2 Send
    • 2.3.3 In-House
  • 2.4 Market Definition
    • 2.4.1 Retail vs. Wholesale
  • 2.5 Application Segments
    • 2.5.1 Channel Segments
    • 2.5.2 Technology Segments
    • 2.5.3 Currency
    • 2.5.4 Years
  • 2.6 Methodology
    • 2.6.1 Methodology
    • 2.6.2 Sources
    • 2.6.3 Authors
  • 2.7 Perspective: Healthcare and the IVD Industry
    • 2.7.1 Global Healthcare Spending
    • 2.7.2 Spending on Diagnostics
    • 2.7.3 Important Role of Insurance for Diagnostics

3 Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Instrumentation Supplier
    • 3.1.4 Chemical/Reagent Supplier
    • 3.1.5 Pathology Supplier
    • 3.1.6 Independent Clinical Laboratory
    • 3.1.7 Public National/regional Laboratory
    • 3.1.8 Hospital Laboratory
    • 3.1.9 Physicians Office Lab (POLS)
    • 3.1.10 Audit Body
    • 3.1.11 Certification Body
  • 3.2 Diagnostic Market Segments
    • 3.2.1 Traditional Market Segmentation
    • 3.2.2 Laboratory Focus and Segmentation
    • 3.2.3 Segmenting the Home Diagnostics Market
  • 3.3 Industry Structure
    • 3.3.1 Hospital Testing Share
    • 3.3.2 Economies of Scale
    • 3.3.3 Hospital vs. Central Lab
    • 3.3.4 Physician Office Lab's
      • 3.3.4.1 The Problem with POLS
    • 3.3.5 Physician's and Home Diagnostics
    • 3.3.6 Pharmacies and Home Diagnostics
      • 3.3.6.1 The Diagnostic Plight of Pharmacies - Trying to do good
      • 3.3.6.2 The Theranos Legacy

4 Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Privacy and Anonymity
    • 4.1.2 The Internet Effect
    • 4.1.3 Rapid Result
    • 4.1.4 The Wellness Movement
    • 4.1.5 The COVID-19 Impact
  • 4.2 Factors Limiting Growth
    • 4.2.1 Trust Factor
    • 4.2.2 Infectious Disease is Declining But....
    • 4.2.3 Wellness Hurts
    • 4.2.4 Economic Growth improves Living Standards
  • 4.3 Diagnostic Technology Development
    • 4.3.1 The Multiplex Paradigm Shift
    • 4.3.2 NAT vs. Lateral Flow
    • 4.3.3 The Unusual Role of GPS
    • 4.3.4 Self and Send Competition
    • 4.3.5 The Relationship to DTC Genetic
    • 4.3.6 The Relationship to TeleHealth
    • 4.3.7 Sample Collection - Who Knew?

5 Home Diagnostics Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
  • 5.2 Health Canada Approves NanoSpeed Diagnostics POC Vitamin D Test
  • 5.3 Visby Medical At-Home MDx STI Test Approved
  • 5.4 Cubit Diagnostics Gets Funding for COVID/Flu Test on Multimodal Platform
  • 5.5 OraSure Technologies Acquires Sherlock Biosciences
  • 5.6 Atomo Diagnostics Awarded Grant for Syphilis Test
  • 5.7 Shuwen Biotech Gets Approval for POC Preeclampsia Test
  • 5.8 Watmind Get Two EUAs
  • 5.9 Capitainer, Life Genomics Partner on Self-Sampling Diagnostics
  • 5.10 MyGeneticScreen Home Test Launched
  • 5.11 Demand for OTC Self-Tests Tempered by Lack of Reimbursement
  • 5.12 DiaCarta OTC Fecal Occult Blood Test Receives FDA Approval
  • 5.13 LetsGetChecked Nabs FDA Authorization for Chlamydia, Gonorrhea Test
  • 5.14 DiagMetrics Developing Breath Assays
  • 5.15 Co-Diagnostics Awarded $2.3M for TB, HPV Tests
  • 5.16 POC Developers Nuclein and Minute Molecular Dx Merge
  • 5.17 ReadyGo Dx to Make MDx Testing a 'Snap'
  • 5.18 Altratech Enters POC Testing Space by Supplanting PCR
  • 5.19 Sherlock Biosciences to Acquire Sense Biodetection
  • 5.20 Scripps Research, Cue Health to Offer Home Based Test-to-Treat Program
  • 5.21 KSL Pulse Scientific to Distribute Home Molecular Test in Canada
  • 5.22 Juno Diagnostics Offers NIPT With At-Home Sample Collection
  • 5.23 Sherlock Biosciences Adds to Diagnostic Toolkit
  • 5.24 Morgan Health Invests in LetsGetChecked
  • 5.25 Prenetics ColoClear by Circle
  • 5.26 Detect to Roll Out Next-Gen Molecular Instrument
  • 5.27 Diagnostics for the Real World Third-Generation POC Platform
  • 5.28 Labcorp Partnering With Getlabs for Home Collection
  • 5.29 Salignostics Closes Funding Round
  • 5.30 Cue Health Targets DTC Market in 2022
  • 5.31 Grip Molecular Developing Home Respiratory Panel
  • 5.32 Mainz Biomed Developing Home ColoAlert Assay
  • 5.33 MFB Fertility Closes Series A Financing Round
  • 5.34 Continued Demand for SARS-CoV-2 Rapid Tests
  • 5.35 Rapid Covid-19 Test Results Risk Going Uncounted
  • 5.36 FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
  • 5.37 Researchers Develop 15-Minute PCR System
  • 5.38 Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
  • 5.39 Lucira Health Files for $115M IPO
  • 5.40 Spectrum Solutions Gets CE Mark for Saliva Collection Devices

6 Profiles of Key Home Diagnostics Companies

  • 6.1 1DropDiagnostics
  • 6.2 23andME Inc.
  • 6.3 Abbott Laboratories
  • 6.4 Accel Diagnostics
  • 6.5 ADT Biotech
  • 6.6 Akonni Biosystems
  • 6.7 AlphaBiolabs
  • 6.8 Alveo Technologies
  • 6.9 Anitoa
  • 6.10 Applied BioCode
  • 6.11 Atomo Diagnostics
  • 6.12 Aureum Diagnostics
  • 6.13 Aus Diagnostics
  • 6.14 Becton, Dickinson and Company
  • 6.15 Binx Health
  • 6.16 Biocartis
  • 6.17 BioFire Diagnostics (bioMerieux)
  • 6.18 bioMerieux Diagnostics
  • 6.19 Bio-Rad Laboratories, Inc
  • 6.20 Bosch Healthcare Solutions GmbH
  • 6.21 Cepheid (Danaher)
  • 6.22 Cue Health
  • 6.23 Curetis (OpGen)
  • 6.24 DBS Systems
  • 6.25 Detect
  • 6.26 Diagenode Diagnostics (Hologic)
  • 6.27 Diasorin S.p.A.
  • 6.28 Domus Diagnostics
  • 6.29 Ellume
  • 6.30 Everywell
  • 6.31 Genomadix
  • 6.32 Getlabs
  • 6.33 Grip Molecular Technologies
  • 6.34 Healthy.io
  • 6.35 Hologic
  • 6.36 Inflammatix
  • 6.37 Invetech
  • 6.38 Iollo
  • 6.39 J&J Innovative Medicine
  • 6.40 Karius
  • 6.41 Laboratory Corporation of America
  • 6.42 Letsgetchecked
  • 6.43 LightDeck Diagnostics
  • 6.44 Lucira Health (Pfizer)
  • 6.45 LumiraDx
  • 6.46 Meep
  • 6.47 MFB Fertility
  • 6.48 myLabBox
  • 6.49 NanoDx
  • 6.50 Nanomix
  • 6.51 OraSure Technologies
  • 6.52 Oxford Nanopore Technologies
  • 6.53 Panagene
  • 6.54 Prenetics
  • 6.55 Primerdesign (Novacyt)
  • 6.56 Prominex
  • 6.57 Proof Diagnostics
  • 6.58 Qiagen
  • 6.59 QuantuMDx
  • 6.60 Quest Diagnostics
  • 6.61 QuidelOrtho
  • 6.62 Randox Toxicology
  • 6.63 Roche Diagnostics
  • 6.64 Salignostics
  • 6.65 SD Biosensor
  • 6.66 Seegene
  • 6.67 Siemens Healthineers
  • 6.68 T2 Biosystems
  • 6.69 TestCard
  • 6.70 Thermo Fisher Scientific
  • 6.71 Thriva
  • 6.72 Visby Medical
  • 6.73 XCR Diagnostics
  • 6.74 YourBio Health

7 Global Market Size

  • 7.1 Home Diagnostics Global Market Size by Country
    • 7.1.1 Home Diagnostics Global Market Size by Country Table
    • 7.1.2 Home Diagnostics Global Market Size by Country Chart
  • 7.2 Home Diagnostics Global Market Size by Application
    • 7.2.1 Home Diagnostics Global Market Size by Application Table
    • 7.2.2 Home Diagnostics Global Market Size by Application Share by Year
    • 7.2.3 Home Diagnostics Global Market Size by Application Base vs Final
    • 7.2.4 Home Diagnostics Global Market Size by Application Base Year
    • 7.2.5 Home Diagnostics Global Market Size by Application Final Year
    • 7.2.6 Home Diagnostics Global Market Size by Application Segment Growth
  • 7.3 Home Diagnostics Global Market Size by Channel
    • 7.3.1 Home Diagnostics Global Market Size by Channel Table
    • 7.3.2 Home Diagnostics Global Market Size by Channel Share by Year
    • 7.3.3 Home Diagnostics Global Market Size by Channel Base vs Final
    • 7.3.4 Home Diagnostics Global Market Size by Channel Base Year
    • 7.3.5 Home Diagnostics Global Market Size by Channel Final Year
    • 7.3.6 Home Diagnostics Global Market Size by Channel Segment Growth
  • 7.4 Home Diagnostics Global Market Size by Technology
    • 7.4.1 Home Diagnostics Global Market Size by Technology Table
    • 7.4.2 Home Diagnostics Global Market Size by Technology Share by Year
    • 7.4.3 Home Diagnostics Global Market Size by Technology Base vs Final
    • 7.4.4 Home Diagnostics Global Market Size by Technology Base Year
    • 7.4.5 Home Diagnostics Global Market Size by Technology Final Year
    • 7.4.6 Home Diagnostics Global Market Size by Technology Segment Growth

8 Global Market by Application

  • 8.1 Respiratory Market
    • 8.1.1 Respiratory Market by Country Table
    • 8.1.2 Respiratory Market Chart
  • 8.2 STD Market
    • 8.2.1 STD Market by Country Table
    • 8.2.2 STD Market Chart
  • 8.3 UTI Market
    • 8.3.1 UTI Market by Country Table
    • 8.3.2 UTI Market Chart
  • 8.4 Pregnancy Market
    • 8.4.1 Pregnancy Market by Country Table
    • 8.4.2 Pregnancy Market by Chart
  • 8.5 Ovulation Market
    • 8.5.1 Ovulation Market by Country Table
    • 8.5.2 Ovulation Market by Chart
  • 8.6 DNA Market
    • 8.6.1 DNA Market by Country Table
    • 8.6.2 DNA Market Chart
  • 8.7 Other Market
    • 8.7.1 Other Market by Country Table
    • 8.7.2 Other Market Chart

9 Global Market by Channel

  • 9.1 Store Market
    • 9.1.1 Store Market by Country Table
    • 9.1.2 Store Market Chart
  • 9.2 Online Market
    • 9.2.1 Online Market by Country Table
    • 9.2.2 Online Market Chart
  • 9.3 Other Channel Market
    • 9.3.1 Other Channel by Country Table
    • 9.3.2 Other Channel Market Chart

10 Global Market by Technology

  • 10.1 Immunoassay Market
    • 10.1.1 Immunoassay Market by Country Table
    • 10.1.2 Immunoassay Market Chart
  • 10.2 Chemistry Market
    • 10.2.1 Chemistry Market by Country Table
    • 10.2.2 Chemistry Market Chart
  • 10.3 Nucleic Acid Market
    • 10.3.1 Nucleic Acid Market by Country Table
    • 10.3.2 Nucleic Acid Market Chart
  • 10.4 Other Technology Market
    • 10.4.1 Other Technology Market by Country Table
    • 10.4.2 Other Technology Market Chart

11 Appendices

  • 11.1 United States Medicare System: Clinical Laboratory Fees Schedule
  • 11.2 The Most Used IVD Assays
  • 11.3 The Highest Grossing Assays

Table of Tables

  • Table 1 Application Segment Definitions
  • Table 2 Channel Segment Definitions
  • Table 3 Technology Segment Definitions
  • Table 4 Market Players by Type
  • Table 5 Clinical Laboratory Departments and Segments
  • Table 6 Laboratory Management Focus - Different Approaches
  • Table 7 Key Segmentation Variables Going Forward
  • Table 8 Possible Market Segments of HOME Market
  • Table 9 Five Factors Driving Growth
  • Table 10 Four Factors Limiting Growth
  • Table 11 Self vs. Send TAT
  • Table 12 Home Diagnostics Global Market by Country/Region
  • Table 13 Home Diagnostics Global Market by Application
  • Table 14 Home Diagnostics Global Market by Channel
  • Table 15 Home Diagnostics Global Market by Technology
  • Table 16 Respiratory by Country
  • Table 17 STD market by country
  • Table 18 UTI Market by country
  • Table 19 Pregnancy Market by country
  • Table 20 Ovulation Market by country
  • Table 21 DNA Market by country
  • Table 22 Other Market by country
  • Table 23 Store Market by Country
  • Table 24 Online market by country
  • Table 25 Other Channel Market by country
  • Table 26 Immunoassay by Country
  • Table 27 Chemistry Market by country
  • Table 28 Nucleic Acid Market by country
  • Table 29 Other Technology Market by country
  • Table 30 Clinical Lab Fee Schedule
  • Table 31 The Most Common Assays
  • Table 32 Largest Revenue Assays

Table of Figures

  • Figure 1 Standard Test Paradigm
  • Figure 2 The New Test Paradigm
  • Figure 3 Global Healthcare Spending
  • Figure 4 The Lab Test Pie
  • Figure 5 The Road to Diagnostics
  • Figure 6 Chart Death Rates and Infectious Disease Decline
  • Figure 6 The Multiplex Paradigm Shift
  • Figure 8 Market Size by Country - Key Countries
  • Figure 9 Chart of Global Market by Application by Year
  • Figure 10 Application Segment Shares Base vs Final
  • Figure 11 Application Share Base Year
  • Figure 12 Application Share Final Year
  • Figure 13 Application Segment Growth Rates
  • Figure 14 Chart of Global Market by Channel by Year
  • Figure 15 Channel Segment Shares Base vs Final
  • Figure 16 Channel Share Base Year
  • Figure 17 Channel Share Final Year
  • Figure 18 Channel Segment Growth Rates
  • Figure 19 Chart of Global Market by Technology by Year
  • Figure 20 Technology Segment Shares Base vs Final
  • Figure 21 Technology Share Base Year
  • Figure 22 Technology Share Final Year
  • Figure 23 Technology Segment Growth Rates
  • Figure 24 Chart - Respiratory Market Growth
  • Figure 25 Chart - STD Market Growth
  • Figure 26 Chart - UTI Market Growth
  • Figure 27 Chart - Pregnancy Market Growth
  • Figure 28 Chart - Ovulation Market Growth
  • Figure 29 Chart - DNA Market Growth
  • Figure 30 Chart - Other Market Growth
  • Figure 31 Chart - Store Market Growth
  • Figure 32 Chart - Online Market Growth
  • Figure 33 Chart - Other Channel Market Growth
  • Figure 34 Chart - Immunoassay Market Growth
  • Figure 35 Chart - Chemistry Market Growth
  • Figure 36 Chart - Nucleic Acid Market Growth
  • Figure 37 Chart - Other Technology Market Growth